You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

Article metrics

Article menu

Download PDFPDF

XML
Paediatrics
Protocol
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

 

Online download statistics by month:

Online download statistics by month: May 2019 to June 2025

AbstractFullPdf
May 201929228853
Jun 201967366695
Jul 201913312140
Aug 201914213439
Oct 201928026044
Nov 201919818231
Dec 201919717653
Jan 202012611818
Feb 202013812426
Mar 2020968922
May 2020797417
Jun 2020746736
Jul 2020838251
Aug 2020767120
Sep 20201038146
Oct 2020948922
Nov 202012412042
Dec 2020766716
Jan 2021948149
Feb 2021767427
Mar 202115114551
Apr 202111710646
May 202113312637
Jun 2021746829
Jul 2021826937
Aug 20211109744
Sep 2021868042
Oct 202113411871
Nov 202119118079
Dec 202115414771
Jan 202217819689
Feb 202215615269
Mar 202213812346
Apr 202213713358
May 202214014955
Jun 202212911947
Jul 202213012744
Aug 2022888132
Sep 202212412548
Oct 202211410240
Nov 202213612847
Dec 202211910951
Jan 2023958839
Feb 202311611151
Mar 202311310041
Apr 202311310343
May 2023605224
Jun 2023646029
Jul 2023585526
Aug 2023878539
Sep 2023575540
Oct 2023918933
Nov 202314612656
Dec 2023736535
Jan 2024675431
Feb 2024756627
Mar 2024655353
Apr 2024766242
May 2024927536
Jun 2024926922
Jul 2024685232
Aug 2024775438
Sep 2024724936
Oct 2024846533
Nov 2024524330
Dec 2024303010
Jan 2025776618
Feb 202511210514
Mar 2025575133
Apr 2025595540
May 2025575146
Jun 2025333414
Total829376672891